Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-17 Sale |
2020-11-19 5:42 pm |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
15,000 | $7.2515 | $108,773 | 9,376,137 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-16 6:43 pm |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
10,000 | $10 | $100,000 | 34,271 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-02 6:05 pm |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
7,200 | $8.06 | $58,032 | 61,708 (Direct) |
View |
| 2020-08-14 Sale |
2020-08-18 8:31 pm |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
2,182 | $4.7096 | $10,276 | 68,908 (Direct) |
View |
| 2020-08-14 Sale |
2020-08-18 8:30 pm |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
2,182 | $4.7096 | $10,276 | 76,633 (Direct) |
View |
| 2020-08-14 Sale |
2020-08-18 8:29 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
2,182 | $4.7096 | $10,276 | 61,408 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-11 Other |
2020-11-13 8:26 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,000,000 | $0 | 10,391,137 (Direct) |
View |
| 2020-11-11 Other |
2020-11-13 8:19 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 9,917 (Indirect) |
View |
Ownership |
2020-10-26 4:35 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | GILEAD SCIENCES INC 10% Owner |
0 | $0 | 5,539,727 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 6:43 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
10,000 | $4.21 | 34,271 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 6:43 pm |
N/A 2026-05-09 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
10,000 | $0 | 34,271 (Direct) |
View |